课题基金 / 基金详情

RISK OF HYPOGLYCEMIA WITH MORNING VS BEDTIME NPH INSULIN FOR TYPE II DIABETES

RISK OF HYPOGLYCEMIA WITH MORNING VS BEDTIME NPH INSULIN FOR TYPE II DIABETES
早晨与睡前 NPH 胰岛素治疗 II 型糖尿病的低血糖风险
批准号：
3786523
负责人：
MATTHEW C RIDDLE
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3786523
关键词：
body physical activity caloric dietary content diabetes mellitus therapy disease /disorder proneness /risk drug administration rate /duration fasting functional ability human subject human therapy evaluation hypoglycemia insulin noninsulin dependent diabetes mellitus

项目摘要

项目成果

MATTHEW C RIDDLE的其他基金

相关文献

中文摘要
翻译
夜间应用NPH胰岛素可控制空腹高血糖
英文摘要
Using NPH insulin in the evening to control fasting hyperglycemia may address the pathophysiology of type II diabetes better than conventional morning dosage. This study tests the relative risk of hypoglycemia when patients are given equal doses of NPH insulin before breakfast or at bedtime under conditions of changing calorie intake and physical activity, simulating daily life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY OF COMBINED INSULIN AND SULFONYLUREA THERAPY FOR TYPE II DIABETES
INSULIN REGIMEN FOR PATIENTS WITH NON-OBESE TYPE-II DIABETES MELLITUS
SAFETY OF COMBINED INSULIN AND SULFONYLUREA THERAPY FOR TYPE II DIABETES
STEROID DIABETES--METABOLIC PATTERNS AND BASIS FOR TREATMENT